-
Article | 2018.04.05
When you arrive
We have introduced dedicated procedures for welcoming newcomers to the Institut Pasteur and helping them to settle in. As a new staff member, you will be invited to a Welcome Day shortly after you arrive, and you can also sign up for other welcome modules.
-
News | 2018.04.05
SODA, a new analysis tool for fluorescence imaging
SODA (Statistical Object Distance Analysis) is a new method for performing automatic statistical analysis on images and determining the spatial distribution of molecules. It has been made available free of charge for the scientific community via Icy and does not require any programming knowledge. This software is applicable to all fluorescence imaging and can be used for either conventional...
-
Document de presse | 2018.04.10
Hepatitis C: a novel point-of-care assay
One of the major challenges identified by the WHO in efforts to eradicate the hepatitis C virus (HCV) is the diagnosis of chronic cases that are generally asymptomatic. Major progress is required for new diagnostic techniques that can be "decentralized", in other words accessed by populations and countries with limited resources. Scientists from the Institut Pasteur and Inserm, in collaboration...
-
News | 2018.04.16
Halima Maïnassara: from field investigator to director of CERMES in Niger
In February 2017, Dr Halima Maïnassara is the first woman from Niger to be appointed Director General of the Center for Medical and Health Research (CERMES) in Niamey. Physician, epidemiologist expert in meningitis, she started to work for this public institution, member of the Institut Pasteur International Network, in February 2005 as a field investigator.Since primary school, Halima Boubacar...
-
News | 2018.04.11
New Pasteur-USP Scientific Platform in Brazil to tackle neurological disorders with a one health approach
A group of scientists are in the process of setting up the first crew of a research taskforce in Brazil, spawn of the University of São Paulo/Institut Pasteur /Fiocruz tripartite agreement signed in 2015. This scientific platform will focus on neurological disorders caused by either infectious agents or as a consequence of degenerative/progressive diseases. Both causes are growing problems in...
-
News | 2018.04.17
Aedes aegypti mosquitoes’ gut microbiota is environmentally determined
For many years, microbiota – all the microorganisms that colonize a host - has been the subject of intensive research in many multicellular organisms. The mosquito Aedes aegypti vector of pathogens responsible for diseases such as dengue or yellow fever, is no exception to this rule. Recent scientific work has shown that the bacteria colonizing the mosquitoe’s digestive tract play a role in their...
-
News | 2018.04.18
Genomics study in Africa: demographic history and deleterious mutations
Scientists from the Institut Pasteur set out to understand how the demographic changes associated with the Neolithic transition also influenced the efficacy of natural selection. By comparing the genome diversity of more than 300 individuals from groups of forest hunter-gatherers (pygmies) and farmers (Bantu-speaking peoples), from western and eastern Central Africa, they discovered that the...
-
News | 2018.04.19
The book “Institut Pasteur: Today's Research, Tomorrow's Medicine” available in US bookstores
On March 27 American booksellers released Institut Pasteur: Today's Research, Tomorrow's Medicine, the French version of which debuted in France last November, corresponding with the start of the 130th year of Institut Pasteur’s existence.This illustrated volume tells the story of 130 years of research and discoveries, all the way through to the current day with Institut Pasteur's current...
-
Page avancée | 2018.04.20
Sanofi - Institut Pasteur Awards
Sanofi, a global diversified healthcare leader, and the Institut Pasteur, an internationally renowned biomedical research centre, jointly created in 2012 the Sanofi - Institut Pasteur Awards to recognize scientists for their past or ongoing research demonstrating real scientific progress in the life sciences.
-
Report | 2018.04.23
Tackling allergies
They disrupt the lives of millions of people in France and can have extremely serious complications. More than one in every four people in Europe currently suffer from allergies, and the World Health Organization predicts that by 2050 half of all those living in industrialized countries will be affected. Allergies are caused by a deregulation of the immune system, which "overreacts" to substances...
